Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience
Authors:
Open Access
- 9 September 2004
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (10) , 1587-1590
Abstract
A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As2O3) between December 1998 and October 2003. Eight cycles of As2O3 (0.15 mg/kg/day) were administered (induction, consolidation and six cycles of maintenance) over a period of 12 months. The median WBC count at diagnosis was 3400/mm3 (range: 800–9800). In all, 10 patients (91%) achieved hematological remission at a mean duration of 48 days (range: 41–60) with all 10 patients achieving molecular remission at a median duration of 81 days (range: 64–109). Toxicity was minimal with leukocytosis in six patients, ichthyosis and hyperpigmentation of skin in five and mild peripheral neuropathy in one patient. One patient who relapsed 6 months after completing therapy achieved a second hematological and molecular remission with As2O3. With a median follow-up of 30 months (range: 4–62), the overall (OS) survival is 91% with a relapse-free survival (RFS) of 81%. As2O3 achieves hematological and molecular remission in majority of newly diagnosed children with APML with minimal toxicity, but long-term follow-up is required to evaluate late effects of As2O3 and study the minimum dose and duration required for a sustained remission.Keywords
This publication has 7 references indexed in Scilit:
- Acute promyelocytic leukaemia in childrenBest Practice & Research Clinical Haematology, 2003
- Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: A single center experienceAmerican Journal of Hematology, 2002
- United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2001
- Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in childrenAnnals of Hematology, 2001
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999
- Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia PatientsBlood, 1999
- All-Trans-Retinoic Acid (ATRA): Pediatric Acute Promyelocytic LeukemiaPediatric Hematology and Oncology, 1998